4-Formyl-N-(2-isopropoxyethyl)benzamide is a linker for antibody-drug-conjugation (ADC).
Catalog Number | Size | Price | Quantity |
---|---|---|---|
BADC-00517 | -- | $-- |
4-Formyl-N-(2-Isopropoxyethyl)benzamide is an important compound in the synthesis of organic molecules, particularly in the pharmaceutical industry. Its unique benzamide structure with the formyl and isopropoxyethyl functional groups makes it a versatile building block for designing various bioactive molecules. One of its primary applications is in the development of anti-inflammatory drugs. The compound’s structural characteristics allow it to interact effectively with certain biological targets, potentially inhibiting the pathways responsible for inflammation. This makes it a valuable component in the formulation of new medications aimed at treating conditions such as arthritis and other inflammatory disorders.
Another significant application of 4-Formyl-N-(2-Isopropoxyethyl)benzamide is in the field of cancer research. Its ability to modify and act as a precursor in synthesizing complex molecules enables researchers to explore new cancer treatment options. Specifically, the compound’s formyl group can engage in various chemical reactions that produce derivatives with potent anti-cancer properties. Research studies have demonstrated that certain derivatives of this benzamide can induce apoptosis in cancer cells, thus offering a potential pathway for developing novel chemotherapeutic agents. By leveraging the compound’s synthesis potential, scientists can create new drugs that may be more effective and have fewer side effects than existing treatments.
4-Formyl-N-(2-Isopropoxyethyl)benzamide is also used in the production of antimicrobial agents. The increasing resistance of microorganisms to existing antibiotics necessitates the continuous search for new compounds with potent antibacterial and antifungal properties. The structural framework of this benzamide allows for modifications that can enhance its activity against a wide range of pathogens. By optimizing the structure, scientists can develop more effective antimicrobial agents that can combat bacteria and fungi that have become resistant to other medications. This application is critical in maintaining public health and addressing the growing challenge of antibiotic resistance.
Lastly, 4-Formyl-N-(2-Isopropoxyethyl)benzamide finds application in the development of neurological drugs. The compound can be tailored to produce molecules that interact with specific neural pathways, offering potential treatments for neurodegenerative diseases such as Alzheimer’s and Parkinson’s. Its ability to cross the blood-brain barrier and interact with neural tissues makes it particularly useful in this regard. By synthesizing derivatives that can modulate neural activity, researchers hope to create drugs that can alleviate or slow the progression of these debilitating conditions. This makes the compound a key player in advancing neurological therapeutic options.
Customer Support
Providing excellent 24/7 customer service and support
Project Management
Offering 100% high-quality services at all stages
Quality Assurance
Ensuring the quality and reliability of products or services
Global Delivery
Ensuring timely delivery of products worldwide
BOC Sciences offers comprehensive services for ADC manufacturing, including antibody modification, linker chemistry, payload conjugation, and formulation development. In particular, our payload-linker customization service offers a convenient and fast raw material channel for many ADC researchers.
BOC Sciences provides one-stop site-specific conjugation services for amino acids, glycans, unnatural amino acids, and short peptide tags. In addition, cysteine conjugation, lysine conjugation, enzymatic conjugation, thio-engineered antibody can also be obtained quickly.
BOC Sciences offers a full range of linkers, including peptide linkers, PEG linkers, click chemistry, PROTAC linkers, non-cleavable linkers, etc. We also provide custom development services for chemically labile linkers and enzymatically cleavable linkers.